EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Little Green Pharma's enterprise value is A$38.80 Mil.
Little Green Pharma's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was A$12.65 Mil. Therefore, Little Green Pharma's EV-to-Revenue for today is 3.07.
The historical rank and industry rank for Little Green Pharma's EV-to-Revenue or its related term are showing as below:
ASX:LGP'
s EV-to-Revenue Range Over the Past 10 Years
Min: -1.52 Med: 3.16 Max: 53.1
Current: 3.07
During the past 4 years, the highest EV-to-Revenue of Little Green Pharma was 53.10. The lowest was -1.52. And the median was 3.16.
ASX:LGP's EV-to-Revenue is ranked worse than 61.85% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs ASX:LGP: 3.07
As of today (2024-04-25), Little Green Pharma's stock price is A$0.13.
Little Green Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.04. Therefore, Little Green Pharma's PS Ratio for today is 3.10.
Little Green Pharma EV-to-Revenue Historical Data
The historical data trend for Little Green Pharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Little Green Pharma's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's EV-to-Revenue falls into.
Little Green Pharma's current Enterprise Value is A$38.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was A$12.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) EV-to-Revenue Explanation
Little Green Pharma's share price for today is A$0.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was A$0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Little Green Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Little Green Pharma (ASX:LGP) Business Description
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:LGP has been successfully added to your